These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 11695085)
1. Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia. Fawzy A Int J Clin Pract Suppl; 2001 Sep; (122):2-22. PubMed ID: 11695085 [No Abstract] [Full Text] [Related]
2. Benign prostatic hyperplasia. Barry M; Roehrborn C Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703 [No Abstract] [Full Text] [Related]
3. Benign prostatic hyperplasia. Barry M; Roehrborn C; Webber R Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916 [No Abstract] [Full Text] [Related]
4. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment]. Pushkar' DIu; Rasner PI; Skobelev PP Urologiia; 2001; (6):48-54. PubMed ID: 11785083 [No Abstract] [Full Text] [Related]
6. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians. Sausville J; Naslund M Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524 [TBL] [Abstract][Full Text] [Related]
7. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. Rosario DJ; Phillips JT; Chapple CR J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409 [TBL] [Abstract][Full Text] [Related]
9. Treatment options for benign prostatic hyperplasia. Portis AJ; Mador DR Can Fam Physician; 1997 Aug; 43():1395-404. PubMed ID: 9266125 [TBL] [Abstract][Full Text] [Related]
10. Treatment and pharmacologic management of BPH in the context of common comorbidities. O'Leary MP Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527 [TBL] [Abstract][Full Text] [Related]
11. [Benign prostatic hyperplasia: variability in practice and guide to action based on scientific evidence]. Baile A; Asua J; Albisu A Aten Primaria; 1999 Feb; 23(3):142-50. PubMed ID: 10095285 [No Abstract] [Full Text] [Related]
12. Diagnosis and management of benign prostatic hyperplasia. Edwards JL Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Hausmann R; Thalmann G; Reich O; Steif CG Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991 [No Abstract] [Full Text] [Related]
14. Enlarged prostate gland. Many treatment options. Mayo Clin Health Lett; 2001 Apr; 19(4):1-3. PubMed ID: 11284232 [No Abstract] [Full Text] [Related]
16. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion. Nickel JC; Saad F Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the patient with benign prostatic hyperplasia. Carlin BI; Resnick ML Compr Ther; 1996 Sep; 22(9):586-91. PubMed ID: 8902350 [No Abstract] [Full Text] [Related]
18. Benign prostatic hyperplasia. The Saudi perspective in the year 2000. Mosli HA; Atwa MA; Mahassini SH Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951 [TBL] [Abstract][Full Text] [Related]
19. What is the best medical treatment for benign prostate hyperplasia? Evans MF; Frank J Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295 [No Abstract] [Full Text] [Related]